Recent Updates
Recently added Catalysts

InnovAge Holding Corp. Common Stock

INNVFDA catalysts, PDUFA dates & pipeline intelligence
$9.05
▲ +0.16 · +1.86%

Financials

Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Quarterly Cash
Unlock full INNV financials and dilution scoring
Quarter by quarter figures, cash trend and dilution risk.
Institutional-grade data · Cancel anytime
52W LOW $3.9452W HIGH $12.64
Volume
37.91 K
Value Traded
2.35 M
Short % Float
8.35%
Days to Cover
2.4
-0.11%Week
-15%1 Month
-23.9%3 Month
+18.71%6 Month

Cash Data

Unlock INNV cash and runway
  • Monthly Burn
  • Burn Trend
  • Dilution Risk
  • SEC Filing

Key Stats

Market Cap
1.23 B
EPS (TTM)
-0.08
P/E Ratio
-
Ent. Value
1.14 B
Total Shares
136.45 M
Float Shares
31.91 M
Insiders
76.61%
Institutions
13.63%

Upcoming Catalysts

FDA decisions, readouts and PDUFA dates · scored by probability of approval

Catalyst Drug / Treatment Stage Prob. of Approval Description Drug Type Therapeutic Area Source
PDUFA
2026
Example Drug
Treatment for example condition requiring FDA review
Phase 3Small MoleculeOncology-
Unlock every INNV catalyst date and PoA score
Every FDA decision, readout and PDUFA date, with drug type, therapeutic area and a PoA score you can trade on.
Institutional-grade data · Cancel anytime
PoA blends historical approval base rates, trial design score and FDA review track record.

INNV Catalyst Timeline

Dated clinical, regulatory and corporate events for InnovAge Holding Corp. Common Stock

Unlock the full INNV catalyst timeline
Every PDUFA date, readout, approval and corporate move, tiered by market impact and updated daily.
Institutional-grade data · Cancel anytime

Past FDA Catalysts and PDUFA Decisions

How INNV actually traded into and out of each decision

Date Drug Catalyst Stage Reaction Event Move % Best Trade %
-Example Drug Phase 3 data readout Phase 3
Unlock all INNV historical catalysts
Institutional-grade data · Cancel anytime
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision

Drug Pipeline Intelligence

No drug pipeline

InnovAge Holding Corp. is a services and tools company (CRO, lab tools or healthcare services). The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.

Clinical Trial Results

Readouts, endpoints and source filings for every INNV program

Drug Name Indication Phase Date Trial Results SummaryTitleSource
Example Drug Example indication for clinical evaluationPhase 32025-12-01The study met its primary endpoint demonstrating statistically significant improvement.Read MorePhase 3 Study Results AnnouncementRead More
Scroll for more · summaries link to the source press release
Unlock every INNV trial readout
Institutional-grade data · Cancel anytime

Inside Trades

Unlock INNV insider buying and selling
Monthly insider buys and sells against the stock price, with the insider sentiment reading.
Institutional-grade data · Cancel anytime
InsiderSideSharesPriceValueDate
DAMATO NICOLEOfficer (CHIEF LEGAL OFFICER)Sell -23,814 304,897 held$8.70 09/25/2026
Unlock the full INNV insider trade log
Institutional-grade data · Cancel anytime

Hedge Fund 13F Activity

Fund % of Portfolio Current MV Shares Owned Activity
Redmile Group, LLC 0.3 % 17.98 M 843.58 K -0.76% ( -6.42 K)
Unlock every fund holding INNV
Every 13F position with quarter over quarter share flow and average entry price.
Institutional-grade data · Cancel anytime
Unlock hedge fund flows in INNV
Shares held by hedge funds each quarter, and who bought or sold.

INNV Institutional Ownership Trends

INNV Short Interest

Shares sold short, counted twice a month.

8.35%
Short % of Float
of tradable shares sold short
2.7M
Shares Sold Short
+127.3% vs prior count
2.4 Moderate
Days to Cover
trading days of normal volume to buy every short share back
1.1M
Avg Daily Volume
the average used for days to cover
Unlock INNV short interest history
Two years of days to cover and shares sold short, with every count and its change.
Institutional-grade data · Cancel anytime

Options Data

Option Volume

Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg

Option Chain Statistics

ExpiryCall VolPut VolVol P/CCall OIPut OIOI P/CIV CallIV Call OI-WtdIV Call Vol-WtdIV PutIV Put OI-WtdIV Put Vol-Wtd
2026-11-20
Unlock INNV option chain statistics
Per-expiry call and put volume, open interest, put-call ratios and implied volatility.
Institutional-grade data · Cancel anytime

Real-Time Option Chain

CallsStrikePuts
LastVolOILastVolOI
No data available
Unlock the live INNV option chain
Live calls and puts by strike: last price, volume and open interest for every expiry.
Institutional-grade data · Cancel anytime

Calls vs Puts by Expiry

CallsPutsLog scale
Unlock INNV options analytics
Institutional-grade data · Cancel anytime

Competitive positioning

How INNV ranks across every disease it competes in

Competitive Position is a premium feature
See how INNV ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial

INNV News

-INNV
Oct 20, 2026
INNVConferences/Events
▲ +1.9%today

InnovAge to Announce Fiscal First Quarter 2027 Financial Results and Host Conference Call Tuesday, November 3, 2026

InnovAge Holding Corp. will release its fiscal first quarter 2027 financial results on November 3, 2026, after market close. A conference call to discuss these results will take place at 5 p.m. E.T. The company emphasizes its commitment to providing comprehensive healthcare programs for frail seniors through the PACE model.

Read more →
-INNV
Sep 23, 2026
INNVGeneral
▼ -15.5%on this news

InnovAge Announces Pricing of Secondary Offering of Common Stock by Selling Stockholders

InnovAge Holding Corp. has announced a secondary offering of 10 million shares of common stock priced at $9.25 each, set to close on September 24, 2026. The offering is conducted by selling stockholders affiliated with Apax Partners and Welsh, Carson, Anderson & Stowe. InnovAge will not receive proceeds from the sale but will cover associated costs.

Read more →
-INNV
Sep 22, 2026
INNVGeneral
▼ -15.5%on this newsshared move

InnovAge Announces Launch of Proposed Secondary Offering of Common Stock by Selling Stockholders

InnovAge Holding Corp. has announced a secondary public offering of 10 million shares of its common stock by affiliated investment funds. The company will not receive any proceeds from this sale but will cover associated costs. The offering is being managed by Barclays, Goldman Sachs, and Wells Fargo, and is part of a registration statement filed with the SEC.

Read more →
-INNV
Sep 8, 2026
INNVGeneral

InnovAge Announces Financial Results for the Fourth Quarter and Fiscal Year Ended June 30, 2026

InnovAge Holding Corp. reported strong financial results for the fiscal year ending June 30, 2026, with total revenues rising to $989.7 million, a 15.9% increase from the previous year. The company significantly reduced its net loss to $0.7 million, down from $35.3 million in 2025. Looking forward, InnovAge provided optimistic financial guidance for Fiscal Year 2027, aiming to enhance its services for seniors.

Read more →
-INNV
Aug 26, 2026
INNVConferences/Events

InnovAge Announces Conference Call to Discuss Fourth Quarter and Fiscal 2026 Financial Results and Participation in Upcoming Wells Fargo Healthcare Conference

InnovAge Holding Corp. will announce its fiscal fourth quarter and full year financial results on September 8, 2026. A conference call will follow at 5 p.m. E.T. Additionally, the company will participate in the Wells Fargo 21st Annual Healthcare Conference on September 9, 2026, at 8:00 AM E.T., with live webcasts available for both events.

Read more →
-INNV
May 12, 2026
INNVGeneral

InnovAge Appoints Jennifer Browne as President and Chief Operating Officer

InnovAge has appointed Jennifer Browne as President and Chief Operating Officer, effective June 8, 2026. With extensive experience in value-based healthcare, Browne's leadership is expected to enhance InnovAge's performance and compliance. She will focus on operational execution, participant experience, and scaling services to reach more seniors. The appointment reflects InnovAge's commitment to sustainable growth and improving care for older adults.

Read more →
-INNV
May 5, 2026
INNVGeneral

INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL THIRD QUARTER ENDED MARCH 31, 2025

InnovAge Holding Corp. reported financial results for the fiscal third quarter ending March 31, 2026, highlighting a 15.5% increase in total revenues to $251.9 million. Despite the revenue growth, the company faced a net loss of $29.9 million compared to a loss of $11.1 million in the same period last year. InnovAge is raising its fiscal 2026 revenue and Adjusted EBITDA guidance, reflecting confidence in future performance improvements driven by recent investments. The overall financial performance shows a mixture of growth in revenues and increased losses, indicating areas for potential concern.

Read more →
-INNV
Feb 5, 2026
INNVGeneral

Proven Senior Care Model Takes Center Stage at the Capitol

InnovAge Holding Corp. met with Colorado lawmakers to advocate for the PACE program, emphasizing its effectiveness in providing comprehensive care for seniors. Seniors shared their positive experiences, highlighting the program's role in maintaining independence and reducing hospitalizations. InnovAge leaders stressed the need for awareness and support for PACE amidst budget discussions.

Read more →
-INNV
Feb 3, 2026
INNVGeneral

INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL SECOND QUARTER ENDED DECEMBER 31, 2025

InnovAge Holding Corp. announced its financial results for the fiscal second quarter ended December 31, 2025, reporting significant improvement in its operating performance. The company achieved total revenues of $239.7 million, up by 14.7% compared to the previous year, alongside a turnaround from a loss to a net income of $11.8 million. Adjusted EBITDA also saw substantial growth, reaching $22.2 million. InnovAge maintains its focus on ensuring sustainable growth and improving healthcare outcomes for its participants.

Read more →
-INNV
Jan 29, 2026
INNVGeneral

InnovAge Expands Board with Appointment of Two Directors

InnovAge Holding Corp. has expanded its Board of Directors by appointing Pavithra Mahesh and Sean Traynor. Both directors bring extensive experience and institutional knowledge, with Mahesh serving on the Quality and Compliance Committee and Traynor on the Compensation, Nominating and Governance Committee. This expansion aims to strengthen InnovAge's strategic direction and enhance its PACE model for senior care.

Read more →
-INNV
Jan 21, 2026
INNVConferences/Events

InnovAge to Announce Fiscal Second Quarter 2026 Financial Results and Host Conference Call Tuesday, February 3, 2026

InnovAge Holding Corp. will release its fiscal second quarter 2026 financial results on February 3, 2026, after market close. A conference call will follow at 5 p.m. E.T. to discuss the results. The company focuses on providing comprehensive healthcare programs for frail seniors through its PACE model, emphasizing quality care and cost reduction.

Read more →
-INNV
Dec 30, 2025
INNVConferences/Events

InnovAge Announces Participation at the 44th Annual J.P. Morgan Healthcare Conference

InnovAge Holding Corp. announced its participation in the 44th Annual J.P. Morgan Healthcare Conference, where CEO Patrick Blair will present on January 12, 2026. The event will be webcast live, allowing broader access to the company's insights and strategies. InnovAge focuses on providing comprehensive healthcare programs for frail seniors, emphasizing quality care and cost reduction.

Read more →
-INNV
Nov 4, 2025
INNVGeneral

INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL FIRST QUARTER ENDED SEPTEMBER 30, 2025

InnovAge Holding Corp. announced strong financial results for the first quarter of fiscal 2026, reporting total revenues of $236.1 million, a 15.1% increase from the same period last year. The company achieved net income of $7.7 million, reversing a net loss from the previous year. Adjusted EBITDA also showed significant growth, up to $17.6 million, reflecting improved operational efficiency. InnovAge continues to focus on expanding its services and enhancing care for frail seniors through its PACE program.

Read more →
-INNV
Sep 9, 2025
INNVGeneral
▲ +6%on this news

INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FISCAL YEAR ENDED JUNE 30, 2025

InnovAge Holding Corp. reported its financial results for the fourth quarter and fiscal year ending June 30, 2025. The company achieved a total revenue of $853.7 million, reflecting an 11.8% increase from the previous year. However, it also reported a significant increase in net loss, rising to $35.3 million, compared to $23.2 million in the prior year. Looking forward, InnovAge issued guidance for fiscal year 2026, estimating expected census and revenue growth, although potential external factors may affect actual performance.

Read more →
-INNV
Feb 4, 2025
INNVGeneral

INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL SECOND QUARTER ENDED DECEMBER 31, 2024

InnovAge Holding Corp. has announced its financial results for the fiscal second quarter ended December 31, 2024, revealing a total revenue of $209 million, which represents a 10.6% increase from the previous year. Despite this growth, the company reported a significant net loss of $13.5 million, a steep increase from $3.8 million a year earlier. The company's contribution margin improved, but the adjusted EBITDA decreased compared to the prior year. Overall, while revenue growth shows promise, the increased losses raise concerns regarding financial sustainability.

Read more →
-INNV
Nov 5, 2024
INNVGeneral

INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL FIRST QUARTER ENDED SEPTEMBER 30, 2024 DENVER, CO.

InnovAge Holding Corp. announced its financial results for the first fiscal quarter ending September 30, 2024, reporting total revenues of $205.1 million, a notable increase from the previous year. The company achieved a 50.6% improvement in its loss before income taxes, which decreased to $5.3 million, and its adjusted EBITDA increased significantly to $6.5 million. However, InnovAge still experienced a net loss of $5.7 million, down from $11 million a year prior. The press release also highlighted increases in their participant census and encouraged investors to note upcoming financial guidance while acknowledging potential external uncertainties.

Read more →
-INNV
Nov 4, 2024
INNVGeneral

Document InnovAge Appoints Michael Scarbrough as New President and Chief Operating Officer and Maria Lozzano as President, Pharmacy Services DENVER

InnovAge has appointed Michael Scarbrough as the new President and Chief Operating Officer and Maria Lozzano as President of Pharmacy Services, effective November 4, 2024. Scarbrough's extensive experience in healthcare is expected to support InnovAge's strategic goals, while Lozzano's promotion is aimed at enhancing pharmacy operations and participant experiences. The transition follows the departure of former COO Christine Bent, who is thanked for her service.

Read more →
-INNV
Sep 10, 2024
INNVGeneral

INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FISCAL YEAR ENDED JUNE 30, 2024 DENVER, CO.

InnovAge Holding Corp. announced its financial results for the fourth quarter and fiscal year ending June 30, 2024. The company reported a year-over-year revenue increase of approximately 11% to $763.9 million, while also improving its net loss to $23.2 million from $43.6 million in the prior year. As part of a commitment to operational excellence, InnovAge expressed confidence in its financial performance and outlined ambitious growth plans for the upcoming fiscal year. The company anticipates an increase in participant census and revenue in FY 2025, indicating a positive outlook.

Read more →
-INNV
Jun 10, 2024
INNVGeneral

INNOVAGE HOLDING CORP. ANNOUNCES $5.0

InnovAge Holding Corp. has announced a $5.0 million share repurchase program, approved by its Board of Directors. The initiative allows the company to buy back its common stock from the open market or through other designated means, depending on various conditions. InnovAge emphasizes a commitment to improving senior care while maintaining a strategic approach to shareholder value by repurchasing shares. The company currently serves around 6,820 participants across 20 centers.

Read more →

About InnovAge Holding Corp. Common Stock

Denver, CO 2,500 employees innovage.com
Headquarters8950 E. LOWRY BOULEVARD, DENVER, CO, 80230
BIOPHARMAWATCH ELITE PLUS
Trade the next INNV catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime